Oncology & Hematology Coding Alert

You Be the Coder :

Code HEM + Biopsy Correctly

Question: Sometimes the oncologist/hematologistsees a patient for the first time; performs an E/M complete with history, exam, and medical decision making; and then decides to perform an unplanned bone marrow biopsy that same visit. May we report both? California Subscriber Answer: You should be able to report both for two reasons: 1. Documentation includes a history, exam, and medical decision making (HEM) separate from the biopsy. 2.The bone marrow biopsy was not the original or preplanned reason for the visit. You should report the biopsy with 38221 (Bone marrow; biopsy, needle, or trocar) and choose the appropriate E/M code based on the documentation. Be sure to append modifier 25 (Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure or other service) to the E/M code to indicate the separate nature of the service. Helpful hint: CPT's Appendix A explains a significant [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All